Peter Llewellyn-Davies, Director at 2invest AG, holds 186.67K shares in Shield Therapeutics (Ticker: GB:STX), holds ― shares in 2invest AG (Ticker: GB:0QBE), holds ― shares in Medigene (Ticker: GB:0QGJ). Most recently, Peter Llewellyn-Davies Bought ― shares of Shield Therapeutics on Dec 13, 2022 for an estimated value of 10.00K.